Immunosuppressive therapy in collagen vascular diseases

Area of Science:

• Dermatology
• Immunology
• Rheumatology

Background:

• Cytotoxic drugs are increasingly used by dermatologists for nonmalignant skin conditions like psoriasis and pemphigus vulgaris.
• While their immunosuppressive effects are recognized in other fields, their use in autoimmune diseases managed by dermatologists remains debated.
• Dermatologists report perceived effectiveness and safety of cytotoxic drugs in treating nonmalignant cutaneous diseases.

Purpose of the Study:

• To discuss the rationale behind using cytotoxic agents in dermatology.
• To present evidence for the effectiveness of cytotoxic drugs in treating progressive systemic sclerosis and systemic lupus erythematosus.
• To evaluate the safety of cytotoxic drug use in specific autoimmune dermatological conditions.

Main Methods:

• Review of existing literature on cytotoxic drug use in dermatology.
• Analysis of anecdotal evidence and clinical experience shared by dermatologists.
• Examination of the theoretical basis for immunosuppression in autoimmune diseases.

Main Results:

• The use of cytotoxic drugs in dermatology for nonmalignant conditions has grown over the last 10-15 years.
• Evidence for the effectiveness and safety of these drugs in progressive systemic sclerosis and systemic lupus erythematosus is presented for discussion.
• The rationale for their use in autoimmune diseases is still considered conjectural by some, despite perceived benefits by users.

Conclusions:

• Cytotoxic drugs are utilized by dermatologists for various nonmalignant skin diseases.
• The effectiveness and safety of cytotoxic agents in treating systemic sclerosis and systemic lupus erythematosus warrant further investigation.
• Further research is needed to solidify the role of cytotoxic drugs in managing specific autoimmune dermatological conditions.